Microarray Market Research Reveals Path To $9.1 Billion By 2030

The microarray market is positioned for remarkable expansion in the coming years, driven by technological advances and growing demand in healthcare and research. This report explores the market's size, key players, emerging trends, and the major segments that are shaping its future trajectory.

Projected Growth and Market Size Outlook for the Microarray Market
The microarray market is set to experience rapid growth, reaching a valuation of $9.1 billion by 2030. This increase corresponds to a compound annual growth rate (CAGR) of 10.2%. Several factors are contributing to this robust expansion, including the rising demand for personalized medicine and continuous improvements in bioinformatics tools. Additionally, the integration of automation within microarray procedures and the expanding use of microarrays in toxicological testing underscore the market's potential. High-throughput genomic analysis is also becoming increasingly essential, reinforcing the market's upward momentum. Key trends that will shape this landscape through the forecast period include the optimization of genomics-driven microarrays, the adoption of cloud-based platforms for data processing, AI-powered interpretation of gene expression, automated manufacturing technologies, and IoT-enabled systems for sample tracking and monitoring.

The microarray market size has grown strongly in recent years. It will grow from $5.62 billion in 2025 to $6.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to growing adoption of gene expression profiling, advances in dna sequencing technologies, increased use of microarrays in cancer research, expansion of drug discovery programs, rising prevalence of genetic disorders.

Download a free sample of the microarray market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10742&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Influential Companies Leading the Microarray Market
The microarray sector is dominated by several prominent firms, including Agilent Technologies Inc., Arrayit Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare Inc., Illumina Inc., Merck KGaA, Microarray Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, RayBiotech Life Inc., Schott Minifab AG, Full Moon Biosystems Inc., CapitalBio Technology Co. Ltd., Roche Diagnostics Ltd., Affymetrix Inc., SCIENION AG, NextGen Sciences Inc., PathogenDx Inc., BioGenomics Limited, BioMicro Systems Inc., Biostatus Limited, Biotechrabbit GmbH, and INanoBio Inc. A notable recent development occurred in May 2024 when Bruker, a US-based manufacturer of analytical instruments and scientific solutions, acquired NanoString Business. This acquisition aims to bolster Bruker's capabilities in life sciences by enhancing its portfolio with NanoString's expertise in DNA and protein microarrays as well as biosensors.

Emerging Innovations and Trends Making Waves in the Microarray Market
One significant focus among microarray companies is the development of chromosomal microarrays, which are revolutionizing genomic medicine and diagnostics. Chromosomal Microarray Analysis (CMA) is propelling research forward by enabling more precise and comprehensive genetic insights. A prime example is Thermo Fisher Scientific's launch in August 2023 of the Applied Biosystems CytoScan HD Accel array. This cutting-edge chromosomal microarray is designed to boost productivity, efficiency, and profitability within cytogenetic laboratories. Offering an industry-best turnaround time of just two days, the array delivers extensive coverage of the human genome, with enhanced analysis across more than 5,000 crucial genomic regions. Its applications span prenatal and postnatal diagnostics, as well as cancer research, marking a significant advancement in the field.

View the full microarray market report:
https://www.thebusinessresearchcompany.com/report/microarray-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Detailed Breakdown of Key Market Segments Influencing Microarray Growth
The microarray market is categorized into key segments based on type, applications, and end-users. By type, it includes DNA Microarray, Protein Microarray, and Other Types. Regarding applications, the segments consist of Disease Diagnosis, Cancer Genomic Analysis, Drug Discovery, Genomic Sequencing, Expression Analysis, Toxicological Research, and other uses. End-user categories include the Pharmaceutical Industry, Biotechnology Industry, Academic and Research Laboratories, and various other users. Further sub-segmentation of DNA Microarrays covers CDNA Microarray, Oligonucleotide Microarray, SNP Microarray, and Comparative Genomic Hybridization (CGH) Microarray. Protein Microarray subcategories include Antibody Microarray, Antigen Microarray, Receptor Microarray, and Enzyme Microarray. Other types encompass Cell Microarray, Tissue Microarray, and RNA Microarray, reflecting the broad diversity of products within this evolving market.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.